Literature DB >> 16047126

Atherosclerosis imaging and circulating blood biomarkers: insights into subclinical atherosclerotic plaque burden and disease activity.

Paul Schoenhagen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16047126     DOI： 10.1007/s10554-005-0765-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN： 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  29 in total

1.  Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology.

Authors:  Carlos A G Van Mieghem; Nico Bruining; Johannes A Schaar; Eugene McFadden; Nico Mollet; Filippo Cademartiri; Frits Mastik; Jurgen M R Ligthart; Gaston A Rodriguez Granillo; Marco Valgimigli; Georgios Sianos; Willem J van der Giessen; Bianca Backx; Marie-Angele M Morel; Gerrit-Anne Van Es; Jonathon D Sawyer; June Kaplow; Andrew Zalewski; Anton F W van der Steen; Pim de Feyter; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

2.  Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.

Authors:  M Schartl; W Bocksch; D H Koschyk; W Voelker; K R Karsch; J Kreuzer; D Hausmann; S Beckmann; M Gross
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

3.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

4.  High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound.

Authors:  E M Tuzcu; S R Kapadia; E Tutar; K M Ziada; R E Hobbs; P M McCarthy; J B Young; S E Nissen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.

Authors:  Allen J Taylor; Lance E Sullenberger; Hyun J Lee; Jeannie K Lee; Karen A Grace
Journal:  Circulation       Date:  2004-11-10       Impact factor: 29.690

6.  Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.

Authors:  A P Burke; A Farb; G T Malcom; Y H Liang; J Smialek; R Virmani
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

7.  B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).

Authors:  E de Groot; J W Jukema; A D Montauban van Swijndregt; A H Zwinderman; R G Ackerstaff; A F van der Steen; N Bom; K I Lie; A V Bruschke
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

8.  Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.

Authors:  Shinya Okazaki; Takayuki Yokoyama; Katsumi Miyauchi; Kazunori Shimada; Takeshi Kurata; Hitoshi Sato; Hiroyuki Daida
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

9.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

Authors:  Patrick W J C Serruys; Pim de Feyter; Carlos Macaya; Norbert Kokott; Jacques Puel; Matthias Vrolix; Angelo Branzi; Marcelo C Bertolami; Graham Jackson; Bradley Strauss; Bernhard Meier
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

10.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.